Építés alatt – nem éles oldal
Belépés
Taking people in Dánia4. fázis

Impact of Early Thyroid Hormone Replacement on Kidney Function and Health-Related Quality of Life in Patients at Risk of Postoperative Hypothyroidism after Hemithyroidectomy: A Randomised Controlled Trial

Key facts

Where
Aarhus N és Herning, DániaSee the 2 sites
Phase
4. fázis

Where in Dánia

  • Region MidtjyllandAarhus N, DániaTaking people
  • Region MidtjyllandHerning, DániaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Region Midtjylland
Trial code
EU 2025-524175-23-00
Record updated
2026. március 3.
Original description
To evaluate whether postoperative treatment with LT4 leads to an improvement in kidney function - measured as change in eGFR - three months after HT, compared to standard care without LT4Read full original descriptionShow less

To evaluate whether postoperative treatment with LT4 leads to an improvement in kidney function - measured as change in eGFR - three months after HT, compared to standard care without LT4

Inclusion: Patients referred for a first hemithyroidectomy; TSH ≥2 mUI/L; eGFR > 30 mL/min/1.73m2; Age 18 years or above; Ability to understand the study information and provide written informed consent; Able and willing to comply with study procedures and attend scheduled visits.

Exclusion: Previous thyroid operation; Initiated treatment with either ACE inhibitors, ARB or SGLT2 after surgery; Treatment with Thycapzole or similar medication with direct effect on thyroid hormones; Concomitant operation for primary hyperparathyroidism (PHPT); Cancer treatment within the last three years; Severe cardio-vascular disease (atrial fibrillation, heart failure etc.); Severe other illness (psychiatric disorder, kidney disease with GFR < 30 etc.); Inability to understand Danish or provide informed consent; Participation in another interventional study that may interfere with outcomes; Planned total thyroidectomy or completion thyroidectomy during follow-up; Pregnancy or plans of pregnancy in the postoperative period; Use of narcotics or alcohol abuse.

EU CTIS 2025-524175-23-00